NATURAL ALTERNATIVES INTERNATIONAL INC Logo

NATURAL ALTERNATIVES INTERNATIONAL INC

A science-based formulator and contract manufacturer of private-label nutritional supplements.

NAII | US

Overview

Corporate Details

ISIN(s):
US6388423021
LEI:
Country:
United States of America
Address:
1535 FARADAY AVENUE, CARLSBAD
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Natural Alternatives International, Inc. (NAI) is a leading formulator and custom contract manufacturer of nutritional supplements. Founded in 1980, the company provides a comprehensive range of private-label services, including custom formulation, manufacturing, quality assurance testing, finished goods packaging, and warehousing. NAI utilizes a science-based partnership approach to help clients design, produce, and market safe and effective vitamins, minerals, herbs, and other nutritional products for the international market. This focus on scientific guidance allows clients to differentiate their brands while ensuring product efficacy and safety.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NATURAL ALTERNATIVES INTERNATIONAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NATURAL ALTERNATIVES INTERNATIONAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NATURAL ALTERNATIVES INTERNATIONAL INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America
BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea
003000
C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America
CCCC
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
Cambrex Logo
United States of America
CBM
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL

Talk to a Data Expert

Have a question? We'll get back to you promptly.